MRTX News and Press, Mirati Therapeutics Inc. From 05/14/19

JPMorgan analyst Anupam Rama says Mirati Therapeutics ( MRTX +1% ) may experience volatility related to Amgen's ( AMGN +0.5% ) fortunes with pipeline candidate AMG 510, in early-stage development for certain types of cancer. More news on: Mirati Therapeutics, Inc., Amgen Inc....

Mirati Therapeutics (NASDAQ: MRTX ): Q1 GAAP EPS of -$1.17. More news on: Mirati Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

SAN DIEGO , April 29, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the first quarter ended March 31, 2019 . First Quarter Highlights January 7 th , we announced a clinical collabor...

Source: Shutterstock The stock market has continued to edge higher and the two major indexes, the Nasdaq ( QQQ ) and S&P 500 ( SPY ), touched the all-time high milestone last week. The steady gain reflects a diminishing concern relating to the pace of a global economic slowdown, as m...

Gainers: ATAI   +29.3% . MRTX   +3.1% . KALA   +3.1% . HPE   +2.4% . PKD   +2.1% . More news on: ATA Inc., Mirati Therapeutics, Inc., Kala Pharmaceuticals, Inc., Stocks on the move, Read more ...

Gainers: PHAS   +31.6% . GWPH   +4.1% . RUHN   +2.9% . IGC   +1.9% . SENS   +1.9% . More news on: PhaseBio Pharmaceuticals, Inc., GW Pharmaceuticals plc, Hangzhou Ruhnn Holding Co.,Ltd, Stocks on the move, Read more ...

SAN DIEGO , April 1, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, will present at the H.C. Wainwright & Co. Global Life Sciences Conference in London, England on Monday, April 8 th at 11:30am BST / 6:30am ET / 3:...

(Rendition of Brain Neurons, Source: NIH) The biotech sector has continued to participate in the market rally. One of the reasons is the strength in biopharma M&A activity, which provides unique support for valuations and particularly assists the small-and-midcap biotech companies. We ...

The following slide deck was published by Mirati Therapeutics, Inc. in conjunction with this Read more ...

SAN DIEGO , March 5, 2019 Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, will present at two upcoming healthcare conferences. Cowen 39 th Annual Healthcare Conference in Boston on Tuesday, March 12 th at 11:20 a.m. ET / 8:20 a.m. PT . O...